StockData
GLAUKOS Corp logo

GLAUKOS Corp (GKOS) stock

GKOSNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 7/30215% above fair value
$243.25−1.63 (-0.67%)

Close on Nov 17, 2026Market cap $14.40BP/E –Yield –

Glaukos price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Glaukos's price to sales ratio was 23.7× on Nov 11, 2026, against 13.0× a year earlier. Over the last 5 years it ranged from 6.5× to 23.9×, with a median of 12.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202623.7×+9.9
2025Dec 31, 202513.8×−9.1
2024Dec 31, 202422.9×+10.2
2023Dec 29, 202312.8×+5.4
2022Dec 30, 20227.3×+0.2
2021Dec 31, 20217.1×−8.4
2020Dec 31, 202015.5×+6.6
2019Dec 31, 20198.9×−3.0
2018Dec 31, 201812.0×+6.1
2017Dec 29, 20175.9×−5.4
2016Dec 30, 201611.3×−0.8
2015Dec 31, 201512.1×–

More Glaukos figures

See a number that looks wrong?